Hoth Therapeutics (HOTH) announced advancements in its intellectual property portfolio through the acquisition and expansion of patent applications to its therapeutic pipeline.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOTH:
- Biotech Alert: Searches spiking for these stocks today
- 3 Penny Stocks to Watch Now, 1/9/25
- Hoth Therapeutics responds to market rumors, says no plans for offering
- Hoth Therapeutics affirms no plans for public, private offering at this time
- Hoth Therapeutics: Strong balance sheet includes over $10M cash, no debt
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue